ONCOSEM ONKOLOJIK SISTEMLER SANAYI VE TICARET A.S.
BBIST:ONCSM87.00
TRY
+2.00
(+2.35%)
ISIN
TREONCO00026
Return %
Stock
S&P 500
1Y
-48.85
14.20
3Y
-51.12
81.12
5Y
- -
68.34
Capital Structure
TRY
•
in mil. unless spec.Working Capital
TRY
•
in mil. unless spec.Growth Rates
TRY
•
in mil. unless spec.Quarterly Revenue
TRY
•
in mil. unless spec.Quarterly Earnings Per Share
TRY
•
in mil. unless spec.Quarterly Dividends Per Share
TRY
•
in mil. unless spec.Company Description
- Full Time Employees
- 408
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Ankara Turkey
- IPO Date
- Jan 4, 2023
- Website
- oncosem.com
- Similar Companies
- Business
- Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. is a Turkey-based medical technology and healthcare manufacturing company specializing in automated chemotherapy compounding systems, oncology drug preparation devices, closed system drug-transfer devices (CSTD), and in vitro diagnostic solutions. Founded in 2008 and headquartered in Ankara, Turkey, the company operates across the medical devices, biotechnology, and specialized hospital services sectors. Oncosem develops, manufactures, and distributes a comprehensive portfolio of medical hardware, consumables, and clinical solutions, which includes automated and robotic chemotherapy drug compounding systems designed to prevent occupational exposure to hazardous cytotoxic agents; closed system drug-transfer devices, vial access adaptors, syringe connectors, and specialized oncology infusion sets engineered to prevent toxic aerosol emissions and fluid leakage; cleanroom equipment, laminar airflow workstations, and cytotoxic drug preparation isolators; turnkey hospital chemotherapy compounding and preparation management services, including cleanroom infrastructure maintenance, calibration, and technical operations; and in vitro diagnostic (IVD) rapid test kits, diagnostic reagents, and laboratory consumables. The company primarily caters to public and private hospitals, university medical centers, oncology clinics, and clinical laboratories across Turkey, while exporting its products to international markets across Europe, the Middle East, and Asia. In recent developments, Oncosem completed its initial public offering on Borsa Istanbul under the ticker ONCSM, expanded its domestic hospital service footprint through the strategic acquisition of Santek Saglik Turizm Tekstil Sanayi ve Ticaret A.S., secured several multi-year automated chemotherapy preparation service contracts and high-volume tenders with the Turkish Ministry of Health and university hospital networks, and expanded its manufacturing infrastructure in Ankara to scale production capacity for its proprietary closed-system transfer devices and export-oriented medical consumables.